Navigation Links
Controlling our brain's perception of emotional events
Date:4/20/2009

Research performed by Nicole Lauzon and Dr. Steven Laviolette of the Schulich School of Medicine & Dentistry at The University of Western Ontario has found key processes in the brain that control the emotional significance of our experiences and how we form memories of them. A lack of proper brain function in this area is what lies beneath such conditions as Schizophrenia and Post-Traumatic Stress Disorder (PTSD). In people who suffer from these conditions emotional experiences can become distorted, causing the person to 'lose touch' with reality. The findings have been published online by The Journal of Neuroscience.

Lauzon, a Doctoral graduate student in the Laviolette laboratory, discovered that specific receptors for the neurotransmitter dopamine can control how the brain processes emotionally significant information as well as memories for those experiences. Using a rodent model of emotional learning and memory formation, the researchers found by increasing the activity of a specific dopamine receptor in a region of the brain called the pre-frontal cortex, it was able to transform a normally insignificant emotional experience into a very strong emotional memory. In contrast, when a different subtype of the dopamine system was activated, it was able to block the ability to recall an emotionally charged experience.

"Our findings have profound implications for understanding how specific brain receptors can control the magnitude of emotional experience and memory formation," says Laviolette.

"Targeting these receptor systems pharmacologically may offer new therapeutic treatments for controlling the emotional perception and memory deficits observed in psychiatric disorders such as Schizophrenia and PTSD." Laviolette is a professor in the Department of Anatomy & Cell Biology and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator.

According to the National Institute of Mental Health, over 280,000 Canadians suffer from Schizophrenia, and approximately 51 million people worldwide.

About eight per cent of the population will have PTSD symptoms at some point in their lives according to the National Center for Post-Traumatic Stress Disorder in the United States.


'/>"/>

Contact: Jeff Renaud
jrenaud9@uwo.ca
519-661-2111 x85165
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. Maternal depression and controlling behavior associated with increased stress response in infants
2. Controlling for size may also prevent cancer
3. Older blacks and Latinos still lag whites in controlling diabetes
4. Scientists discover tiny RNAs play a big role in controlling genes
5. AARP CEO Bill Novelli Tells Lawmakers: Controlling Health Care Costs Key to Budget Reform
6. TIGroup Acquires Controlling Interest in Healthcare Services Provider
7. Jefferson scientists uncover role of cancer stem cell marker: controlling gene expression
8. Controlling health destiny
9. Hispanics have more difficulty controlling diabetes than non-Hispanic whites
10. Math model identifies key to controlling epidemic
11. Novel mechanisms controlling insulin release and fat deposition discovered
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier ... professionals caring for those suffering from the full spectrum of disordered eating, announced today ... disorders professionals from nearly all 50 states and several countries converged on the Green ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the ... product – with nearly 2,000 consumers (and counting) already backing the campaign. ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward ... Learning How to Walk with God #TruthwithGrace” is the creation of published author ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The IPF pipeline is very strong with a total of ... Co., Inc., Biogen and Sanofi are involved in the development of the ... one is in Phase III stage, 15 are in Phase II stage, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: